Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study it to compare the efficacity of isatuximab when combined to carfilzomib and dexamethasone versus carfilzomib and dexamethasone in patients with multiple myeloma already treated with 1 to 3 prior lines of therapy.
Epistemonikos ID: c67e4faaf218547345934e8bc2300e7575cc063e
First added on: May 21, 2024